Danicopan, an Oral Complement Factor D Inhibitor, Exhibits High and Sustained Exposure in Ocular Tissues in Preclinical Studies
Author:
Affiliation:
1. Alexion, AstraZeneca Rare Disease, New Haven, CT, USA
Publisher
Association for Research in Vision and Ophthalmology (ARVO)
Subject
Ophthalmology,Biomedical Engineering
Reference46 articles.
1. Current therapeutic developments in atrophic age-related macular degeneration;Hanus;Br J Ophthalmol,2016
2. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target;Boyer;Retina,2017
3. The progression of geographic atrophy secondary to age-related macular degeneration;Fleckenstein;Ophthalmology,2018
4. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial;Age-Related Eye Disease Study 2 Research Group;JAMA,2013
5. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8;Age-Related Eye Disease Study Research Group;Arch Ophthalmol,2001
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic innovations for geographic atrophy: A promising horizon;Current Opinion in Pharmacology;2024-10
2. Emerging Oral Pharmaceuticals for Dry Age-Related Macular Degeneration: Mechanism of Action, Current Clinical Status, and Future Directions;Ophthalmic Surgery, Lasers and Imaging Retina;2024-09
3. Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer;Scientific Reports;2024-08-09
4. The Complement System as a Therapeutic Target in Retinal Disease;Medicina;2024-06-05
5. Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration;Archives of Pharmacal Research;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3